| |
2006-present |
|
Representative to Faculty Council for the Department of Reproductive Biology, Case School of Medicine, Case Western Reserve University, Cleveland, OH |
2005 - present |
Director of Resident Research |
Department of Obstetrics and Gynecology, MacDonald Women's Hospital, University Hospitals, Cleveland, OH |
| 2000 - 2002 |
Chief |
Division of Gynecologic Oncology, Akron General Medical Center, Akron, OH |
2000 - 2002 |
Director |
Basic Science Research, Department of Obstetrics and Gynecology, Summa Health Systems |
2002 |
Director |
Medical Student Clerkship, Department of Obstetrics and Gynecology, Northeastern Ohio University College of Medicine (NEOUCOM), Akron General Medical Center, Akron, OH |
| 2001 - 2002 |
Director |
Gynecologic Oncology Clinical Elective for NEOUCOM Medical Students, Akron General Medical Center, Akron, OH |
| 2001 - 2002 |
Director |
Gynecologic Oncology Research Elective for NEOUCOM Medical Students, Akron General Medical Center, Akron, OH |
|
| |
von Gruenigen VE, Daly BJ. Futility: Clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 2005; 97(2):638-644.
von Gruenigen VE, Gil KM, Frasure HE, Grandon M, Hopkins MP, Jenison EL. Complementary medicine use, diet, and exercise in endometrial cancer survivors. J Cancer Integ Med 2005;3:13-18.
von Gruenigen VE, Frasure HE, Grandon M, Jenison EL, Hopkins MP. Impact of obesity and age on quality of life in gynecologic surgery. Am J Obstet Gynecol 2005;193: 1369-1375.
Uyar D, Frasure HE, Cybulski K, Markman M, von Gruenigen VE. Treatment patterns by decade of life in elderly women ( >70 years of age) with ovarian cancer. Gynecol Oncol 2005; 98(3): 403-408.
von Gruenigen VE, Daly BJ. Treating ovarian cancer patients at the end of life: when should we stop? Gynecol Oncol 2005; 99:255-256.
Gil KM, Frasure HE, Jenison EL, Hopkins MP, von Gruenigen VE. Body weight and composition changes in ovarian cancer patients during primary chemotherapy. Accepted Gynecol Oncol 2006.
von Gruenigen VE, Frasure HE, Grandon M, Hopkins MP, Jenison EL, Gil KM. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol 2006; 103:120-126.
von Gruenigen VE, Hutchins JR, Reidy AM, Gibbons HE, Daly BJ, Eldermire EM, Fusco NL. Gynecologic oncology patients’ satisfaction and symptom severity during palliative chemotherapy. Health Qual Life Outcomes 2006;4;84.
von Gruenigen VE, Tian C, Frasure H, Waggoner S, Barakat RR. Treatment toxicity, disease recurrence and survival as related to obesity in women with early endometrial carcinoma: A Gynecologic Oncology Group Study. Cancer 2006; 107:2786-91.
von Gruenigen VE, Frasure HE, Gibbons K, Hopkins MP, Jenison EL. Surgical treatments for vulvar and vaginal dysplasia: A randomized controlled trial. Obstet Gynecol 2007;109:942-947.
Daly BJ, Douglas SL, Foley H, Lipson A, Liou CF, Bowman K, Kwilosz D, Koroukian S, O’Toole E, Smyth K, Townsend A, von Gruenigen V, Rose J. Psychosocial registry for persons with cancer: a method of facilitating quality of life and symptom research. Psycho-Oncology 2007;16:1-7.
Gil KM, Gibbons HE, Hopkins MP, Jenison EL, von Gruenigen VE. Baseline characteristics influencing quality of life in gynecologic cancer. Health Qual Life Outcomes 2007; 5(1):25-
Martra F, Kunos C, Gibbons H, Zola P, Galletto L, DeBernardo R, von Gruenigen VE.
Adjuvant treatment and survival in obese women with endometrial cancer: An international collaborative study. Am J Obstet Gynecol Accepted 2007
|
